Searched for
FOSUN PHARMA INDUSTRIAL
Gland Pharma slides further on weak Q2, stress at FosunThe pessimistic outlook by the rating agency triggered speculation that the Chinese firm may likely sell its stake in the Indian pharma com...01 Nov, 2022, 06.13 AM IST- Hong Kong halts Pfizer/BioNTech COVID-19 vaccines, investigates defective packagingThe government said it had received notice from Fosun Pharma Industrial (Hong Kong), the distributor of the Pfizer/BioNTech vaccine in the ...24 Mar, 2021, 09.17 AM IST
- Gland Pharma IPO receives 22% bids on Day 2Progressive Share Brokers said the sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that Sa...10 Nov, 2020, 06.45 PM IST
- Gland Pharma IPO off to lacklustre start, subscribed 4% on Day 1The IPO is a mix of a fresh issue of shares worth Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.09 Nov, 2020, 05.50 PM IST
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuationsGland Pharma’s IPO is India’s largest pharmaceutical IPO ever.08 Nov, 2020, 04.28 PM IST
- Grey market premium fizzles out for Gland Pharma after fixing price bandThe Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer...06 Nov, 2020, 02.09 PM IST
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per shareThe Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...04 Nov, 2020, 12.23 PM IST
- Gland Pharma gets Sebi's go-ahead to float IPOThe company filed draft papers in July and obtained Sebi's observation on October 19 to float an IPO, an update with the capital markets sh...26 Oct, 2020, 04.39 PM IST
- China’s Fosun pulls out of $300 million healthcare deals amid negative sentimentAccording to sources, both deals were at an advanced stage, and Fosun had formally proposed terms for acquiring a stake in the companies, o...15 Jul, 2020, 08.43 AM IST
- China’s Fosun plans D-Street debut for Gland PharmaThe Hyderabad-based Gland Pharma has filed a draft red herring prospectus with capital market regulator Securities and Exchange Board of In...13 Jul, 2020, 08.41 AM IST
- Gland Pharma seeks pitches from investment bankers to go publicGland Pharma, which is owned 74% by the Chinese major, is seeking a valuation of $3 billion, which is more than twice that of the valuation...31 Aug, 2018, 07.31 AM IST
- After Gland, Chinese pharma giant Fosun eyes API maker SymbiotecSymbiotec has been an acquisition target for other drug makers and PE players after the Indore-based company was put up for sale.01 Oct, 2017, 11.55 PM IST
- FIPB refers Gland Pharma proposal to CCEA for approvalGland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Compa...24 Apr, 2017, 08.59 PM IST
- Two Chinese companies hit roadblock with Indian investmentsIn June 2016, India allowed automatic approval for foreign investments up to 74% in pharmaceutical manufacturing.06 Jan, 2017, 01.03 AM IST
- Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland PharmaThe deal with Fosun is also an example of the excellence of India’s manufacturing capabilities. It goes with the essence of the Make in Ind...01 Aug, 2016, 09.00 AM IST
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.28 Jul, 2016, 12.49 AM IST
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...06 Jun, 2016, 01.25 AM IST
Load More
